These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 9815929)

  • 1. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C; Sobrero A; Faderan MA; Bertino JR
    Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity.
    Longo GS; Izzo J; Chang YM; Tong WP; Zielinski Z; Gorlick R; Chou TC; Bertino JR
    Clin Cancer Res; 1998 Feb; 4(2):469-73. PubMed ID: 9516938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E; Zinn S; Boarman D; Allegra CJ
    Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
    Wadler S; Wersto R; Weinberg V; Thompson D; Schwartz EL
    Cancer Res; 1990 Sep; 50(18):5735-9. PubMed ID: 1697499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J; Hedley DW; Erlichman C
    Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
    Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
    Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
    Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
    Huang Y; Horvath CM; Waxman S
    Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
    J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
    Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines.
    van der Wilt CL; Kuiper CM; Peters GJ
    Oncol Res; 1999; 11(8):383-91. PubMed ID: 10803742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G
    Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.